Clinical Trial Update: A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) [The RETRO Study]

View source ↗

Summary

A retrospective, open-label cohort study evaluating the effectiveness and safety of lactulose retention enema for treating hepatic encephalopathy in cirrhotic p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• lactulose retention enema (lactulose)

Snippet

Sponsor: Abbott | Conditions: Hepatic Encephalopathy | Status: COMPLETED | Results posted: 2020-02-10